GMAB
Genmab AS
35.70$
+0.3%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +36.1% | +34.2% | +26.1% | +28.1% | +79.0% | +39.6% | +16.5% | +22.3% | +17.2% | +29.8% | -72.0% | |
| – | +32.6% | +33.5% | +23.7% | +22.7% | +87.8% | +34.6% | +21.0% | +24.1% | +17.4% | -15.9% | -89.7% | |
| – | +143.4% | -64.9% | +338.9% | -60.5% | +566.5% | +104.4% | +23.4% | +10.4% | +50.3% | -33.7% | -82.6% | |
| – | +31.3% | +12.3% | +38.3% | +12.6% | +79.7% | +46.6% | +20.3% | +15.4% | +26.0% | -25.0% | -91.9% | |
| – | +65.0% | +458.6% | -40.7% | +129.2% | +125.3% | -17.6% | +36.7% | +69.6% | -13.4% | +35.3% | -82.8% | |
| – | – | – | – | -100.0% | – | – | – | – | – | +8.8% | -71.0% | |
| – | – | +11.7% | +252.3% | +42.8% | +155.6% | +77.8% | +32.5% | +35.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -86.0% | |
| – | +208.1% | -5.6% | -31.6% | +278.1% | -0.1% | -28.1% | -24.9% | -42.5% | -30.8% | +12,120.8% | -26.3% | |
| – | -50.1% | -1.0% | -19.6% | +35.0% | +145.4% | +84.5% | +20.2% | +16.7% | +29.7% | +147.7% | -23.1% | |
| – | -36.8% | -0.7% | -20.5% | +35.5% | +111.6% | +33.6% | +25.1% | +16.3% | +36.3% | +113.7% | -73.2% | |
| – | -50.2% | +52,113.6% | -100.0% | – | – | +61.5% | +47.6% | +19.4% | +21.6% | +2.2% | +216.3% | |
| – | -69.8% | -30.4% | +2,499.8% | +129.2% | +125.3% | -95.2% | +141.4% | +390.3% | +34.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +71.5% | +38.4% | +29.9% | +27.8% | +75.3% | +36.1% | +16.1% | +22.9% | +15.9% | +16.1% | -84.1% | |
| – | – | – | – | – | – | +233.7% | +41.0% | +47.8% | +28.5% | +23.8% | -82.6% | |
| – | +6.2% | +1.6% | +0.5% | -0.1% | +2.6% | +3.5% | +0.2% | -0.1% | -0.1% | -1.9% | -3.0% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.